Sign in
4

Changes in Ownership

Context Therapeutics Inc. Filed Acc 0001628280-26-010616

Options or other derivatives

  • Chief Executive Officer acquired 815,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Lehr Martin A. · Chief Executive Officer

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2026-02-19 Grant or award : show line 1 in the form Stock Option (right to buy) +815,000 815,000 D
Loading xslF345X05/wk-form4_1771881235.xml…